Zevra Therapeutics Inc. (ZVRA)
NASDAQ: ZVRA
· Real-Time Price · USD
9.57
0.26 (2.79%)
At close: Oct 03, 2025, 2:29 PM
2.79% (1D)
| Bid | 9.56 |
| Market Cap | 537.29M |
| Revenue (ttm) | 62.02M |
| Net Income (ttm) | 2.64M |
| EPS (ttm) | -0.25 |
| PE Ratio (ttm) | -38.29 |
| Forward PE | 17.15 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 11.9 |
| Volume | 713,825 |
| Avg. Volume (20D) | 1,771,936 |
| Open | 9.30 |
| Previous Close | 9.31 |
| Day's Range | 9.30 - 9.75 |
| 52-Week Range | 6.19 - 13.16 |
| Beta | 1.50 |
| Ex-Dividend Date | n/a |
About ZVRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZVRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ZVRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsZevra Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-19.81%
Zevra Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
3 months ago
+5.14%
Zevra Therapeutics are trading higher after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced a $26 price target.
